Emerging druggable targets for cardiovascular disease.
Curtis
Michael J
MJ
Cardiovascular Division, King's College London, School of Medicine, Rayne Institute, St Thomas' Hospital, London SE17EH, UK. michael.curtis@kcl.ac.uk
D002318:Cardiovascular Diseases / Q000188:drug therapy*; D016503:Drug Delivery Systems; D055808:Drug Discovery; D054769:G-Protein-Coupled Receptor Kinase 2 / Q000502:physiology; D006801:Humans; D008954:Models, Biological
C496567:GRK2 protein, human; D054769:G-Protein-Coupled Receptor Kinase 2